Docoh
Loading...

Cho Alex

Filed: 9 Dec 20, 6:15pm
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
CHO ALEX

(Last) (First) (Middle)
C/O HP INC.
1501 PAGE MILL ROAD

(Street)
PALO ALTO CA 94304

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
HP INC [ HPQ ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
President, Personal Systems
3. Date of Earliest Transaction (Month/Day/Year)
12/07/2020
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 12/07/2020 M 73,955(1) A $0.00 101,102 D
Common Stock 12/07/2020 F 36,669(2) D $23.68 64,433 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Restricted Stock Unit (3) 12/07/2020 A 92,905 (3) (3) Common Stock 92,905 (3) 92,905 D
Performance Adjusted Restricted Stock Units (4) 12/07/2020 A 58,559 (4) (4) Common Stock 58,559 (4) 58,559 D
Performance Contingent Stock Options $23.68 12/07/2020 A 259,706 (5) (5) Common Stock 259,706 (5) 259,706 D
Restricted Stock Unit (6) 12/07/2020 M 32,465 (6) (6) Common Stock 32,465 (6) 62,440 D
Restricted Stock Unit (7) 12/07/2020 M 24,933 (7) (7) Common Stock 24,933 (7) 11,753 D
Restricted Stock Unit (8) 12/07/2020 M 16,557 (8) (8) Common Stock 16,557 (8) 0.00 D
Explanation of Responses:
1. Each RSU represents a contingent right to receive one share of HP common stock.
2. 36,669 shares were withheld by HP to satisfy tax withholding on vesting of RSUs.
3. On 12/7/2020, the reporting person was granted 92,905 RSUs, one-third of which vest annually over three years on each of 12/7/2021, 12/7/2022 and 12/7/2023. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on HP common stock.
4. On 12/7/2020, the reporting person was granted 58,559 Performance Adjusted Restricted Stock Units ("PARSUs"), 100% of which will only be earned after certification of financial results as of 10/31/23, subject to certain earnings per share and relative total stockholder return conditions being met as of that date. Dividend equivalent rights accrue with respect to these PARSUs when and as dividends are paid on HP common stock.
5. The performance contingent stock options granted on 12/7/2020 will vest 33.3% on each of the first two anniversaries of the grant date, and 33.4% on the third anniversary, in each case subject to the satisfaction of certain stock price performance conditions being met within five years following the grant date.
6. On 12/6/2019, the reporting person was granted 93,659 RSUs, 31,219 of which vested on 12/7/2020, and of which 31,220 is scheduled to vest on 12/7/2021 and 12/7/2022. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on HP common stock. The number of derivative securities in column 5 includes 1,246 vested dividend equivalent rights.
7. On 12/7/2018, the reporting person was granted 35,258 RSUs, 11,752 which vested on 12/7/2019 and of which vested 11,753 on 12/7/2020 and of which 11,753 is expected to vest on 12/7/2021. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on HP common stock. The number of derivative securities in column 5 includes 1,674 vested dividend equivalent rights.
8. On 12/7/2017, the reporting person was granted 45,303 RSUs, 15,101 of which vested on 12/7/2018, 12/7/2019 and 12/7/2020. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on HP common stock. The number of derivative securities in column 5 includes 1,456 vested dividend equivalent rights.
Remarks:
/s / Ruairidh Ross, Attorney-in-Fact for CHO ALEX 12/09/2020
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.